consumers should review OpenLoop's telehealth consent at openloophealth.com/telehealth-consent and ask FeelGood support specific data privacy questions before enrollment FDA compounded GLP-1 adverse events: The FDA received 1,150+ adverse event reports related to compounded semaglutide/tirzepatide as of July 2025, including dosing errors with vial-based injectables
Brain RNA was isolated from wild-type BALB/cCrSlcNifdc mice and homozygous B-Glp1r KO mice(C) (-/-), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse Glp1r primers
International Journal of Surgery (London, England), 109 (2), 8182
Conclusion GLP-1 therapies have shown promise in improving heart health and supporting weight loss, with major trials highlighting their ability to reduce key cardiovascular events across a variety of patient groups
According to FDA prescribing information, gastrointestinal side effects are typically most pronounced during dose initiation and escalation, and they often diminish over time as the body adapts to the medication
Ayala JE, Bracy DP, Hansotia T, et al
